Skip to content
The Nexus
DossierENTITY

drug companies

Coverage of drug companies in the Nexus archive.

Earliest in view: Jun 4 · 20:53 UTCMost recent: Jun 4 · 20:53 UTC
Co-mentioned in this coverage
FDAorganization1Marty Makaryperson1Commissioner’s National Priority Voucher programtopic1patient groupsorganization1academic organizationsorganization1national prioritiestopic1
Recent coverage
  • HEALTHJun 4 · 20:53 UTCSTAT NEWS
    STAT+: Drug companies, patient groups urge FDA to pause commissioner’s voucher program

    Leaders at the FDA held a listening session on the Commissioner’s National Priority Voucher program, which offers expedited drug reviews for companies aligning with vague national priorities. While some speakers supported the program, most urged the FDA to pause it and restart through standard regulatory processes due to concerns about political interference.

drug companies · Dossier · The Nexus